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Tracheoesophageal voice (TEV) with voice prosthesis 
(VP) is an efficient and reproducible method used in vocal 
rehabilitation after total laryngectomy (TL), prevented 
by spasms in the pharyngoesophageal segment (PES). 
Computerized Manometry (CM) is a new, direct and 
objective method used to assess the PES. Aim: to carry 
out an objective analysis of the PES, with CM, before and 
after the injection of botulinum toxin (BT). Study design: 
clinical-prospective. Materials and Methods: analysis of 
eight patients consecutively submitted to TL with TEV and 
VP, without vocal emission, with PES spasms seen through 
videofluoroscopy, considered the gold standard for spasm 
detection. All had their spasms treated with the injection of 
100 units of BT in the PES. The assessment was based on 
PES videofluoroscopy and CM, before and after BT injection. 
Results: There was a PES pressure reduction according 
to the CM after BT injection in all patients. The average 
pressure in the PES seen through the CM in eight patients 
before BT injection was 25.36 mmHg, and afterwards it 
dropped to 14.31 mmHg (p=0.004). There was vocal emission 
without stress and PES spasm improvement seen through 
the videolaryngoscopy after BT injection. Conclusion: We 
observed a reduction in PES pressure after BT injection, seen 
through CM in all the patients, with spasms improvement 
seen through videofluoroscopy.
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INTRODUCTION
Between 9% and 79% of the patients rehabilitated 
after total laryngectomy (TL) with tracheoesophageal 
speech (TES) and speech prosthesis (SP) after primary 
or secondary tracheoesophageal puncture (TEP) present 
stress-related speech difficulty associated to changes in 
the motility of the pharyngoesophageal segment (PES), 
secondary to its pharyngospasm1-13. This PES alteration 
can be treated in three different ways: myotomy of mi-
ddle and lower pharynx constrictors, neurectomy of the 
pharyngeal plexus, and the recently published technique 
of chemically denervating the PES with botulinum toxin 
(BT)6-8,10,11,14-24. Botulinum toxin is a pre-synaptic blocker 
that prevents the release of acetylcholine in the neuro-
muscular junction. PES relaxation after BT application in 
the region can be seen through videofluoroscopy3,4,7,15,25. 
However, small variations cannot be quantified. There are 
indirect assessment methods that use PES pressure, as the 
modified insufflation test4,6,15, measurement of intratracheal 
pressure and speech time duration7,18. This study was de-
veloped to objectively quantify PES relaxation in spastic 
total laryngectomy patients after BT injection and relate it 
to improvements in speech quality. Esophageal manometry 
was used to measure PES median pressure before and after 
BT injection in the spastic area.
MATERIALS AND METHOD
Eight consecutive patients seen in our institution 
between January of 2004 and October of 2006 with TES 
under stress and speech time of one second or less were 
included in this study. All had indwelling Blom-Singer 
(Inhealth®) speech prosthesis inserted after primary or 
secondary TEP. The patients were included in this study 
after at least six months of speech rehabilitation sessions. 
The speech rehabilitation sessions done with the total 
laryngectomy patients with TES and SP were conducted 
by one same experienced specialized therapist.
This study was approved by the ethics committee 
at our institution under permit 546/2005. Informed con-
sent terms were collected from all patients participating 
in the study.
Tests conducted with the patients included assess-
ment of mean speech time, acoustic analysis, swallowing 
and speech videofluoroscopy, 4-channel esophageal 
manometry with pneumocapillary  infusion and compu-
terized polygraph before and after injection of 100U of 
BT (Botox®) in the PES spastic area. Mean speech time 
was measured using a Tissot® stopwatch after three con-
secutive takes in which the patients were asked to utter 
the vowel /a/ in a prolonged manner after maximum air 
inhalation. Speech acoustic assessment was done at the 
speech lab using software package MDVP (Multidimen-
sional Voice Program) by Kay Elemetrics Corporation. 
Patients were requested to utter and sustain vowel /a/. The 
acoustic parameter used to assess speech was presence 
or absence of harmonics. Speech samples were recorded 
with a Teac W518R recorder in chrome cassette tapes and 
using a Prologue microphone placed 5 centimeters from 
the patients’ mouths. Speech samples were recorded in a 
soundproof booth with noise level treatment. Videofluo-
roscopy was considered the golden standard to diagnose 
PES spasm. All patients complained of dysphagia. Botuli-
num toxin injections were applied in each third of the PES 
(Fig. 1) under electromyographic control of pharyngeal 
constrictor muscles without local anesthesia. Pharyngeal 
constrictor muscle punctures were done by the author, and 
electromyographic tracings interpreted by one same spe-
cialist. A Compass Portabook II Nicolet electromyograph 
connected to a Compaq® workstation was used.
Statistical analysis done for speech time, PES pres-
sure, presence or absence of harmonics, and PES vide-
ofluoroscopy findings before and after BT injection was 
done using the Binomial test. A significance level of 0.05 
was considered.
Figure 1. Schematic representation of areas of botulinum toxin injection 
on the three thirds of the pharyngoesophageal segment.
RESULTS
Manometry findings indicated a reduction in the PES 
mean pressure after botulinum toxin injection in all eight 
patients (Table 1 and Fig. 2). Mean PES pressure before 
BTY injection was 25.36 mmHg. After BT injection the PES 
mean pressure dropped to 14.31 mmHg (p=0.004).
Harmonics were identified in a statistically signi-
ficant manner (p=0.004) in all patients during acoustic 
analysis after BT injection in the PES (Fig. 3). Before 
treatment none of the patients could produce harmonics. 
Effortless voice production was possible in these patients 
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Table 1. Pharyngoesophageal segment pressure under esophageal 
manometry before (PRE) and after (POST) injecting 100 U of botuli-
num toxin.
PATIENT PRE POST
1 33,0 mmHg 12,2 mmHg
2 17,27 mmHg 12,50 mmHg
3 16,79 mmHg 13,71 mmHg
4 32,7 mm Hg 19,6 mmHg
5 30,0 mmHg 14,1 mmHg
6 16,5 mmHg 13,6 mmHg
7 23,1 mmHg 15,4 mmHg
8 33,5 mmHg 13,4 mmHg
Figure 2a
Figure 2. Pressure measurements in the pharyngoesophageal seg-
ment for each channel under esophageal manometry before (a) and 
after (b) botulinum toxin injection. Each base line corresponds to one 
channel. Pharyngoesophageal segment pressure indication with arrows 
in each base line.
Figure 2b
Figure 3a
Figure 3b
Figure 3. Computerized acoustic tests before (a) and after (b) botuli-
num toxin injection in the pharyngoesophageal segment. Harmonics 
observed after botulinum toxin injection (b) not seen before BT injection. 
Arrow indicating harmonic.
with increased speech time (p=0.004). Before treatment 
with BT, their speech time was insignificant (Table 2). 
PES videofluoroscopy during speech showed significant 
improvements (p=0.004) in PES spasm (Fig. 4) for all 
patients. No adverse effects were associated to BT use. 
Clinical improvements in dysphagia were observed in all 
patients. Patients were followed for 15 to 48 months after 
BT injection, and none of the patients required additional 
BT injections.
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DISCUSSION
PES spasm is a reflex movement triggered by the 
entrance of air in the esophagus that prevents air from 
moving into the pharynx. Thus, the pharyngeal mucosa 
does not vibrate and speech is not possible1,3-5,7-9,13,18. 
Spasms can be observed during speech tests under 
videofluoroscopy5,7,8,15,25 with relaxation during swallowing. 
In constriction there is no relaxation during swallowing. 
The treatment in this case is dilation4,5,25. Spasm is a me-
chanism devised to protect us against gastropharyngeal 
reflux, but in TL patients it becomes an obstacle to speech 
rehabilitation7,8,13,25.
BT injections in the PES were initially described in 
1994 by Schneider et al.26 in the treatment of swallowing 
disorders with upper esophageal sphincter hypertrophy 
or hypertonia. The authors used dosages ranging from 80 
and 120 units. BT was used initially to treat PES spasm 
after TEP and introduction of SP by Blitzer et al.16. Some 
authors have shown effects for as long as two years and 
three months after initial use of BT, with no need of 
additional injections18. A possible explanation is that after 
the first injection the patients will readapt to the new 
circumstances18.
In primary TEP, myotomy of the middle and lower 
pharyngeal constrictor muscles is one of the stages of the 
described surgical approach12,27. Such procedure may be 
related to increased incidence of postoperative salivary 
fistulas8,12. Salivary fistulas mean longer hospital stays, hi-
gher care costs, delays in speech rehab, later introduction 
of oral feeding, and delays in postoperative radiotherapy. 
The actual need for myotomy in TEP is controversial, and 
ranges from 9% to 79% among TL patients as reported in 
the literature1-13, as most patients with PES spasm improve 
spontaneously form this motor disorder six months into 
Figure 4a
Figure 4b
Figure 4. Videofluoroscopy examination showing lateral view during 
speech before (a) and after (b) botulinum toxin injection on the pha-
ryngoesophageal segment. Arrow indicates spastic area in the pha-
ryngoesophageal segment before injection (a) and spasm-free after 
injection (b) with increased anteroposterior distance.
Table 2. Median speech time in seconds before and after injecting 
100 U of botulinum toxin in the pharyngoesophageal segment.
Patient
Speech time (s)
BEFORE AFTER
1 1,0 9,0
2 1,0 7,0
3 1,0 7,0
4 1,0 7,5
5 1,0 8,0
6 1,0 8,5
7 1,0 6,8
8 1,0 7,0
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follow-up on average1. On secondary TEP, myotomy is 
related to an incidence of salivary fistulas of 10-20%27 
and the same consequences previously described may 
occur. The use of BT instead of myotomy to approach 
patients with PES spasm enables the selection of only the 
cases requiring PES treatment. Only patients presenting 
PES spasm are treated, as after six months many improve 
spontaneously from the condition or even do not see it 
develop1. BT injections are applied in an outpatient setting 
with the patient seated and awaken, while the pharyngeal 
constrictor muscles are monitored through electromyogra-
phy. This procedure is less expensive that performing a 
myotomy of the pharyngeal constrictor muscles17, and does 
not present the complications inherent to the myotomy, 
such as salivary fistula and PES hypotonia, the latter lacking 
a definitive solution and leading to hypotonic speech. One 
should bear in mind that even after performing a myotomy 
on the medial and lower pharyngeal constrictor muscles 
spasms may occur as the muscle fibers draw closer to 
each other again1,7,10,11,17; botulinum toxin injections may 
then also be used.
Speech time evaluation is an indirect method to 
assess PES spasm in patients rehabilitated with TES and 
SP7. When speech time is under eight seconds, the patient 
may have PES spasm7. In this study we observed that all 
patients with PES spasm improved after BT injection as 
seen in videofluoroscopy examination. PES pressure was 
reduced as observed in esophageal manometry tests, and 
improvements were observed in speech time.
As all patients with TES and SP had marked alte-
rations in their speech when compared to laryngeal spe-
ech, the only parameter left for evaluation was presence 
or absence of harmonics under computerized acoustic 
analysis. As patients with spasm could not speak, they 
could not produce harmonics. After PES BT injection and 
improving from spasm, all patients could speak, conse-
quently producing harmonics as observed in computerized 
acoustic tests.
Objective evaluation of PES spasm can be done 
through measurements of intratracheal pressure, in which 
levels greater than 40cm of H
2
O may trigger spasms18. The 
modified insufflation test can also be used with the same 
purpose, in which pressures above 20 mmHg10,15 indicate 
spasm. Using videofluoroscopy with image digital analysis 
also allows the measurement of spasm during speech. 
Esophageal manometry is another objective method to 
analyze PES relaxation after BT injection in the rehabilita-
tion of TL patients with spasm. Total laryngectomy patients 
have median PES pressures lower than that of individuals 
with larynx28. A previous study observed that median PES 
pressures after neurectomy of the pharyngeal plexus for 
the treatment of spasm resulted in statistically significant 
pressure reduction and found that pressure values greater 
than 20 mmHg can be used to separate patients with spasm 
from patients without spasm29. In this study we looked 
objectively into PES intraluminal pressure before and after 
BT injection. Reductions in PES pressure under esophageal 
manometry were correlated to improved speech quality. 
Pressure levels were reduced in all patients. Computerized 
esophageal manometry is an objective method that can be 
used in the assessment of patient response to PES spasm 
treatment after BT injection in TL patients, rehabilitated 
with TES and SP.
CONCLUSION
Computerized esophageal manometry is an objec-
tive method that allows the quantification of PES intralu-
minal pressure and may be viable in the analysis of the 
effect of BT injections in this site.
Statistically significant (p<0.05) PES pressure reduc-
tions observed under esophageal manometry were seen 
in all patients after PES BT injection.
All patients had increases in their speech time values 
after BT injection (p<0.05).
All PES spasm patients who took BT injections 
presented PES pressure reduction and improved spasm 
under videofluoroscopy (p<0.05).
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